The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
The Duke of Cambridge told crowds he was "delighted" to be back in the Commonwealth country.
When and where are they on, and how do they work?
What better, more dramatic spectacle has there ever been on American television?